Halozyme Therapeutics Inc (NASDAQ:HALO)
| 34.50 Delayed Data As of Mar 24 |  +0.82 / +2.43%Today’s Change | 32.83 Today|||52-Week Range 59.46 | -39.37% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Torley Helen I President & Chief Executive Officer |  Sale | 2/12/2023 | 17,266 | $48.92 | $844.7K | -29.76% |
Torley Helen I President & Chief Executive Officer | Sale | 2/10/2023 | 16,469 | $48.92 | $805.7K | -29.50% |
Posard Matthew L Director | Sale | 12/02/2022 | 10,000 | $58.80 | $588.0K | -41.98% |
Posard Matthew L Director | Sale | 12/06/2022 | 10,000 | $56.12 | $561.2K | -38.83% |
Posard Matthew L Director | Sale | 12/05/2022 | 10,000 | $55.74 | $557.4K | -38.34% |
Torley Helen I President & Chief Executive Officer | Sale | 2/16/2023 | 11,061 | $49.26 | $544.9K | -29.98% |
Torley Helen I President & Chief Executive Officer | Sale | 1/19/2023 | 10,000 | $52.41 | $524.1K | -32.79% |
Torley Helen I President & Chief Executive Officer | Sale | 2/08/2023 | 10,000 | $51.36 | $513.6K | -31.46% |
Torley Helen I President & Chief Executive Officer | Sale | 2/07/2023 | 10,000 | $51.26 | $512.6K | -33.25% |
Torley Helen I President & Chief Executive Officer | Sale | 1/18/2023 | 10,000 | $51.05 | $510.5K | -34.52% |
Page of 7